These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24442229)

  • 1. Short-term effectiveness and safety of third-line antiretroviral regimens among patients in Western India.
    Pujari SN; Makane A; Lodha A; Bele V; Joshi K
    J Acquir Immune Defic Syndr; 2014 Feb; 65(2):e82-4. PubMed ID: 24442229
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiretroviral reduction: is it time to rethink the unthinkable?
    Colasanti J; Marconi VC; Taiwo B
    AIDS; 2014 Apr; 28(7):943-7. PubMed ID: 24401641
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune Reconstitution in Severely Immunosuppressed Antiretroviral-Naive HIV-1-Infected Patients Starting Efavirenz, Lopinavir-Ritonavir, or Atazanavir-Ritonavir Plus Tenofovir/Emtricitabine: Final 48-Week Results (The Advanz-3 Trial).
    Miro JM; Manzardo C; Ferrer E; Loncà M; Guardo AC; Podzamczer D; Domingo P; Curran A; Clotet B; Cruceta A; Lozano F; Pérez I; Plana M; Gatell JM;
    J Acquir Immune Defic Syndr; 2015 Jun; 69(2):206-15. PubMed ID: 25831464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.
    Williams PL; Hazra R; Van Dyke RB; Yildirim C; Crain MJ; Seage GR; Civitello L; Ellis A; Butler L; Rich K;
    AIDS; 2016 Jan; 30(1):133-44. PubMed ID: 26731758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa.
    Ciaffi L; Koulla-Shiro S; Sawadogo A; le Moing V; Eymard-Duvernay S; Izard S; Kouanfack C; Ngom Gueye NF; Fobang AA; Reynes J; Calmy A; Delaporte E;
    AIDS; 2015 Jul; 29(12):1473-81. PubMed ID: 26244387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral Therapy-associated Adverse Drug Reactions and their Effects on Virologic Failure- A Retrospective Cohort Study in Nigeria.
    Abah IO; Ncube NBQ; Bradley HA; AgbaJi OO; Kanki P
    Curr HIV Res; 2018; 16(6):436-446. PubMed ID: 30767743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, randomized, multicentre trial (IMEA 040 DATA trial).
    Slama L; Landman R; Assoumou L; Benalycherif A; Samri A; Joly V; Pialoux G; Valin N; Cabié A; Duvivier C; Lambert-Niclot S; Marcelin AG; Peytavin G; Costagliola D; Girard PM;
    J Antimicrob Chemother; 2016 Aug; 71(8):2252-61. PubMed ID: 27068399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa.
    Onoya D; Hirasen K; van den Berg L; Miot J; Long LC; Fox MP
    Drug Saf; 2018 Dec; 41(12):1343-1353. PubMed ID: 30043384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monotherapy with boosted PIs as an ART simplification strategy in clinical practice.
    Santos JR; Llibre JM; Berrio-Galan D; Bravo I; Miranda C; Pérez-Alvarez S; Pérez-Alvarez N; Paredes R; Clotet B; Moltó J
    J Antimicrob Chemother; 2015 Apr; 70(4):1124-9. PubMed ID: 25525196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse Drug Reactions in HIV/AIDS Patients at a Tertiary Care Hospital in Penang, Malaysia.
    Khan K; Khan AH; Sulaiman SA; Soo CT; Akhtar A
    Jpn J Infect Dis; 2016; 69(1):56-9. PubMed ID: 26073728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral drug-related toxicities - clinical spectrum, prevention, and management.
    Fernandez-Montero JV; Eugenia E; Barreiro P; Labarga P; Soriano V
    Expert Opin Drug Saf; 2013 Sep; 12(5):697-707. PubMed ID: 23730950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reactions associated with antiretroviral therapy during pregnancy.
    Santini-Oliveira M; Grinsztejn B
    Expert Opin Drug Saf; 2014 Dec; 13(12):1623-52. PubMed ID: 25390463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: a phase I/II, randomized trial.
    Thacher EG; Cavassini M; Audran R; Thierry AC; Bollaerts A; Cohen J; Demoitié MA; Ejigu D; Mettens P; Moris P; Ofori-Anyinam O; Spertini F
    AIDS; 2014 Jul; 28(12):1769-81. PubMed ID: 24911353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse Drug Reactions to Antiretroviral Therapy in HIV-Infected Patients at the Largest Public Hospital in Nicaragua.
    Lorío M; Colasanti J; Moreira S; Gutierrez G; Quant C
    J Int Assoc Provid AIDS Care; 2014; 13(5):466-70. PubMed ID: 24935691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to first-line antiretroviral regimens in Rwanda.
    Demeester R; Omes C; Karasi JC; Schneider S; Mugabo J; Maliboli MJ; Arendt V
    J Acquir Immune Defic Syndr; 2005 Sep; 40(1):113-4. PubMed ID: 16123694
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of antiretroviral drug therapy in Jamaican children with HIV/AIDS.
    Pryce C; Pierre RB; Steel-Duncan J; Evans-Gilbert T; Palmer P; Moore J; Rodriguez B; Christie CD
    West Indian Med J; 2008 Jun; 57(3):238-45. PubMed ID: 19583122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety of antiretroviral drugs.
    Tymchuk CN; Currier JS
    Expert Opin Drug Saf; 2008 Jan; 7(1):1-4. PubMed ID: 18171309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No adverse safety or virological changes 2 years following vorinostat in HIV-infected individuals on antiretroviral therapy.
    Mota TM; Rasmussen TA; Rhodes A; Tennakoon S; Dantanarayana A; Wightman F; Hagenauer M; Roney J; Spelman T; Purcell DFJ; McMahon J; Hoy JF; Prince HM; Elliott JH; Lewin SR
    AIDS; 2017 May; 31(8):1137-1141. PubMed ID: 28301423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older.
    Ranzani A; Oreni L; Agrò M; van den Bogaart L; Milazzo L; Giacomelli A; Cattaneo D; Gervasoni C; Ridolfo AL
    J Acquir Immune Defic Syndr; 2018 Jun; 78(2):193-201. PubMed ID: 29767640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nature and prevalence of adverse drug reaction of antiretroviral medications in Halibet National Referral Hospital: a retrospective study.
    Hagos L; Fessehaye S; Anand IS
    BMC Pharmacol Toxicol; 2019 May; 20(1):24. PubMed ID: 31060603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.